# US 2009/0024195 A1 · Method and apparatus for renal neuromodulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0024195 A1
- Document ID: US20090024195A1
- Status: Published application
- Kind: A1
- Application number: 12/101,452
- Filed: 2008-04-11
- Published: 2009-01-22
- Earliest claimed: 2007-04-11
- Assignees: The Cleveland Clinic Foundation
- Inventors: Ali R. Rezai; Roy K. Greenberg; Milind Deogaonkar
- Web page: https://patentgrep.com/patent/US20090024195A1

## CPC

- A61N 1/36007: {of urogenital or gastrointestinal organs, e.g. for incontinence control}
- A61N 1/0558: {Anchoring or fixation means therefor}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

An apparatus for renal neuromodulation includes an expandable support member having a main body portion for engaging a wall of a blood vessel proximate a renal vasculature and at least one electrode connected with the main body portion. The at least one electrode is arranged to selectively deliver electric current to a desired location where modulation of the sympathetic nervous system is effective to alter renal function. The apparatus further includes an insulative material attached to at least a portion of the main body portion for isolating blood flow through the vessel from the electric current delivered by the at least one electrode.

## Claims

### Claim 1

An apparatus for renal neuromodulation, said apparatus comprising:
an expandable support member having a main body portion for engaging a wall of a blood vessel proximate a renal vasculature;
at least one electrode connected with said main body portion, said at least one electrode arranged to selectively deliver electric current to a desired location where modulation of the sympathetic nervous system (SNS) is effective to alter renal function; and
an insulative material attached to at least a portion of said main body portion, said insulative material for isolating blood flow through the vessel from the electric current delivered by said at least one electrode.

### Claim 2 (depends on 1)

The apparatus of claim 1, wherein modulation of the parasympathetic nervous system (PNS) is effective to alter renal function.

### Claim 3 (depends on 1)

The apparatus of claim 1, wherein modulation of the PNS and the SNS is effective to alter renal function.

### Claim 4 (depends on 1)

The apparatus of claim 1, where said expandable support member further includes at least one fenestration.

### Claim 5 (depends on 1)

The apparatus of claim 1, wherein said expandable support member further includes at least one branch member for engaging a wall of a blood vessel in the renal vasculature, said at least one branch member including first and second end portions and at least one electrode arranged to selectively deliver electric current to a desired location where modulation of the SNS is effective to alter renal function, said first end portion being anastomosed with said at least one fenestration.

### Claim 6 (depends on 1)

The apparatus of claim 1, wherein said insulative material is disposed radially inward of said at least one electrode.

### Claim 7 (depends on 6)

The apparatus of claim 6, wherein said expandable support member is disposed radially inward of said insulative material.

### Claim 8 (depends on 6)

The apparatus of claim 6, wherein said insulative material is disposed radially inward of said expandable support member.

### Claim 9 (depends on 6)

The apparatus of claim 6, wherein said at least one electrode is disposed radially inward of said expandable support member.

### Claim 10 (depends on 1)

The apparatus of claim 1, wherein said insulative material extends the entire length of said expandable support member.

### Claim 11 (depends on 1)

The apparatus of claim 1, wherein the at least one electrode is arranged to deliver a focal electric current to the desired location.

### Claim 12 (depends on 1)

The apparatus of claim 1, wherein at least one magnetic member for generating an electromagnetic field is securely attached to said expandable support member.

### Claim 13 (depends on 1)

The apparatus of claim 1, wherein said expandable support member further includes at least one pharmacological agent for chemically modulating the SNS.

### Claim 14 (depends on 1)

The apparatus of claim 1, wherein said expandable support member further includes at least one biological agent for biologically modulating the SNS.

### Claim 15 (depends on 1)

The apparatus of claim 1, wherein at least one sensor for measuring at least one metabolic parameter of interest is securely attached to said expandable support member.

### Claim 16 (depends on 15)

The apparatus of claim 15, wherein said at least one sensor is positioned in or on a blood vessel.

### Claim 17 (depends on 15)

The apparatus of claim 15, wherein said at least one sensor is positioned in or on an organ.

### Claim 18

An apparatus for renal neuromodulation, said apparatus comprising:
an expandable support member for engaging a wall of a blood vessel proximate a renal vasculature, said expandable support member including a main body portion having at least one fenestration and at least one branch member for engaging a wall of a blood vessel in the renal vasculature, said at least one branch member having first and second end portions, said first end portion being anastomosed with said at least one fenestration;
at least one electrode connected with said expandable support member, said at least one electrode being arranged to selectively deliver electric current to a desired location where modulation of the sympathetic nervous system (SNS) is effective to alter renal function; and
an insulative material attached to at least a portion of said expandable support member, said insulative material for isolating blood flow through the vessel from the electric current delivered by said at least one electrode.

### Claim 19 (depends on 18)

The apparatus of claim 18, wherein modulation of the parasympathetic nervous system (PNS) is effective to alter renal function.

### Claim 20 (depends on 18)

The apparatus of claim 18, wherein modulation of the PNS and the SNS is effective to alter renal function.

### Claim 21 (depends on 18)

The apparatus of claim 18, wherein said at least one electrode is connected to each of said main body portion and said at least one branch member.

### Claim 22 (depends on 18)

The apparatus of claim 18, wherein said at least one electrode is connected to said main body portion.

### Claim 23 (depends on 18)

The apparatus of claim 18, wherein said at least one electrode is connected to said at least one branch member.

### Claim 24 (depends on 18)

The apparatus of claim 18, wherein said insulative material is disposed radially inward of said at least one electrode.

### Claim 25 (depends on 18)

The apparatus of claim 18, wherein said expandable support member is disposed radially inward of said insulative material.

### Claim 26 (depends on 18)

The apparatus of claim 18, wherein said insulative material is disposed radially inward of said expandable support member.

### Claim 27 (depends on 18)

The apparatus of claim 18, wherein said at least one electrode is disposed radially inward of said expandable support member.

### Claim 28 (depends on 18)

The apparatus of claim 18, wherein said insulative material extends the entire length of said expandable support member.

### Claim 29 (depends on 18)

The apparatus of claim 18, wherein the at least one electrode is arranged to deliver a focal electric current to the desired location.

### Claim 30 (depends on 18)

The apparatus of claim 18, wherein at least one magnetic member for generating an electromagnetic field is securely attached to said expandable support member.

### Claim 31 (depends on 18)

The apparatus of claim 18, wherein said expandable support member further includes at least one pharmacological agent for chemically modulating the SNS.

### Claim 32 (depends on 18)

The apparatus of claim 18, wherein said expandable support member further includes at least one biological agent for biologically modulating the SNS.

### Claim 33 (depends on 18)

The apparatus of claim 18, wherein at least one sensor for measuring at least one metabolic parameter of interest is securely attached to said expandable support member.

### Claim 34 (depends on 33)

The apparatus of claim 33, wherein said at least one sensor is positioned in or on a blood vessel.

### Claim 35 (depends on 33)

The apparatus of claim 33, wherein said at least one sensor is positioned in or on an organ.

### Claim 36

An apparatus for renal neuromodulation, said apparatus comprising:
an expandable support member having a main body portion for engaging a wall of a blood vessel proximate a renal vasculature;
at least one electrode connected with said main body portion, said at least one electrode arranged to selectively deliver electric current to a desired location where modulation of the sympathetic nervous system (SNS) is effective to alter renal function; and
at least one wireless module capable of receiving electrical energy for delivery to said at least one electrode.

### Claim 37 (depends on 36)

The apparatus of claim 36, wherein modulation of the parasympathetic nervous system (PNS) is effective to alter renal function.

### Claim 38 (depends on 36)

The apparatus of claim 36, wherein modulation of the PNS and the SNS is effective to alter renal function.

### Claim 39 (depends on 36)

The apparatus of claim 36, wherein said expandable support member further includes an insulative material attached to at least a portion of said main body portion, said insulative material for isolating blood flow through the vessel from the electric current delivered by said at least one electrode.

### Claim 40 (depends on 36)

The apparatus of claim 36, wherein said expandable support member further includes at least one fenestration.

### Claim 41 (depends on 36)

The apparatus of claim 36, wherein said expandable support member further includes at least one branch member for engaging a wall of a blood vessel in the renal vasculature, said at least one branch member including first and second end portions and at least one electrode arranged to selectively deliver electric current to a desired location where modulation of the SNS is effective to alter renal function, said first end portion being anastomosed with said at least one fenestration.

### Claim 42 (depends on 41)

The apparatus of claim 41, wherein said insulative material is disposed radially inward of said at least one electrode.

### Claim 43 (depends on 41)

The apparatus of claim 41, wherein said expandable support member is disposed radially inward of said insulative material.

### Claim 44 (depends on 41)

The apparatus of claim 41, wherein said insulative material is disposed radially inward of said expandable support member.

### Claim 45 (depends on 36)

The apparatus of claim 36, wherein said at least one electrode is disposed radially inward of said expandable support member.

### Claim 46 (depends on 36)

The apparatus of claim 36, wherein said insulative material extends the entire length of said expandable support member.

### Claim 47 (depends on 36)

The apparatus of claim 36, wherein the at least one electrode is arranged to deliver a focal electric current to the desired location.

### Claim 48 (depends on 36)

The apparatus of claim 36, wherein at least one magnetic member for generating an electromagnetic field is securely attached to said expandable support member.

### Claim 49 (depends on 36)

The apparatus of claim 36, wherein said expandable support member further includes at least one pharmacological agent for chemically modulating the SNS.

### Claim 50 (depends on 36)

The apparatus of claim 36, wherein said expandable support member further includes at least one biological agent for biologically modulating the SNS.

### Claim 51 (depends on 36)

The apparatus of claim 36, wherein at least one sensor for measuring at least one metabolic parameter of interest is securely attached to said expandable support member.

### Claim 52 (depends on 51)

The apparatus of claim 51, wherein said at least one sensor is positioned in or on a blood vessel.

### Claim 53 (depends on 51)

The apparatus of claim 51, wherein said at least one sensor is positioned in or on an organ.

### Claim 54

A method for renal neuromodulation, said method comprising the steps of:
providing an expandable support member having a main body portion for engaging a wall of a blood vessel proximate a renal vasculature, at least one electrode connected with the main body portion arranged to selectively deliver electric current to a desired location, and an insulative material attached to at least a portion of the main body portion for isolating blood flow through the vessel from the electric current delivered by the at least one electrode;
implanting the main body portion intravascularly so that the main body portion is proximate a renal vasculature and at least one electrode is positioned substantially adjacent a desired location where modulation of the sympathetic nervous system (SNS) is effective to alter renal function; and
delivering electric current to the at least one electrode to effect a change in the SNS.

### Claim 55 (depends on 54)

The method of claim 54, wherein said step of implanting the main body portion intravascularly includes positioning the at least one electrode substantially adjacent a desired location where modulation of the PNS and the SNS is effective to alter renal function.

### Claim 56 (depends on 54)

The method of claim 54, wherein said step of implanting the main body portion intravascularly includes positioning the at least one electrode substantially adjacent a desired location where modulation of the parasympathetic nervous system (PNS) is effective to alter renal function.

### Claim 57 (depends on 54)

The method of claim 54, wherein the change in the SNS includes a change in neurohormonal activation.

### Claim 58 (depends on 54)

The method of claim 54, wherein said step of implanting the main body portion further includes positioning at least a portion of the main body portion substantially adjacent a desired location in an aortic arterial wall.

### Claim 59 (depends on 54)

The method of claim 54, wherein said step of implanting the main body portion further includes positioning at least a portion of the main body portion substantially adjacent a desired location in a vena cava venous wall.

### Claim 60 (depends on 54)

The method of claim 54, wherein the change in the SNS is chemically induced by at least one pharmacological agent associated with the expandable support member.

### Claim 61 (depends on 54)

The method of claim 54, wherein the change in the SNS is biologically induced by at least one biological agent associated with the expandable support member.

### Claim 62 (depends on 54)

The method of claim 54, wherein delivery of electric current to the at least one electrode modulates the level of renin.

### Claim 63 (depends on 54)

The method of claim 54, wherein delivery of electric current to the at least one electrode modulates at least one of urine production and blood pressure.

### Claim 64 (depends on 54)

The method of claim 54, wherein delivery of electric current to the at least one electrode modulates vasoconstriction or blood vessel tone.

### Claim 65 (depends on 54)

The method of claim 54, wherein delivery of electric current to the at least one electrode modulates efferent neuronal activity.

### Claim 66 (depends on 54)

The method of claim 54, wherein delivery of electric current to the at least one electrode modulates afferent neuronal activity.

### Claim 67 (depends on 54)

The method of claim 54, wherein delivery of electric current to the at least one electrode modulates both efferent and afferent neuronal activity.

### Claim 68

A method for renal neuromodulation, said method comprising the steps of:
providing an expandable support member for engaging a wall of a blood vessel proximate a renal vasculature, the expandable support member including a main body portion having at least one fenestration and at least one branch member having first and second end portions, the first end portion being anastomosed with the at least one fenestration, at least one electrode connected with the expandable support member arranged to selectively deliver electric current to a desired location, and an insulative material attached to at least a portion of the expandable support member for isolating blood flow through the vessel from the electric current delivered by the at least one electrode;
implanting the main body portion intravascularly so that the main body portion is proximate a renal vasculature and at least one electrode is positioned substantially adjacent a desired location where modulation of the sympathetic nervous system (SNS) is effective to alter renal function;
deploying the at least one branch member such that the at least one branch member is positioned in the renal vasculature and at least one electrode is positioned substantially adjacent a desired location where modulation of the SNS is possible; and
delivering electric current to one or both of the at least one electrode to effect a change in the SNS.

### Claim 69 (depends on 68)

The method of claim 68, wherein said step of delivering electric current to one or both of the at least one electrode effects a change in the parasympathetic nervous system (PNS).

### Claim 70 (depends on 68)

The method of claim 68, wherein said step of delivering electric current to one or both of the at least one electrode effects a change in the PNS and the SNS.

### Claim 71 (depends on 68)

The method of claim 68, wherein said step of deploying the at least one branch member further comprises anastomosing the first end portion of the at least one branch member with the at least one fenestration.

### Claim 72 (depends on 68)

The method of claim 68, wherein the change in the SNS includes a change in neurohormonal activation.

### Claim 73 (depends on 68)

The method of claim 68, wherein said step of implanting the main body portion further includes positioning at least a portion of the main body portion substantially adjacent a desired location in an aortic arterial wall.

### Claim 74 (depends on 68)

The method of claim 68, wherein said step of implanting the main body portion further includes positioning at least a portion of the main body portion substantially adjacent a desired location in a vena cava venous wall.

### Claim 75 (depends on 68)

The method of claim 68, wherein said step of deploying the at least one branch member further includes positioning at least a portion of the at least one branch member substantially adjacent a desired location in a renal arterial wall.

### Claim 76 (depends on 68)

The method of claim 68, wherein said step of deploying the at least one branch member further includes positioning at least a portion of the at least one branch member substantially adjacent a desired location in a renal venous wall.

### Claim 77 (depends on 68)

The method of claim 68, wherein the change in the SNS is chemically induced by at least one pharmacological agent associated with the expandable support member.

### Claim 78 (depends on 68)

The method of claim 68, wherein the change in the SNS is biologically induced by at least one biological agent associated with the expandable support member.

### Claim 79 (depends on 68)

The method of claim 68, wherein delivery of electric current to the at least one electrode modulates the level of renin.

### Claim 80 (depends on 68)

The method of claim 68, wherein delivery of electric current to the at least one electrode modulates at least one of urine production and blood pressure.

### Claim 81 (depends on 68)

The method of claim 68, wherein delivery of electric current to the at least one electrode modulates vasoconstriction or blood vessel tone.

### Claim 82 (depends on 68)

The method of claim 68, wherein delivery of electric current to the at least one electrode modulates efferent neuronal activity.

### Claim 83 (depends on 68)

The method of claim 68, wherein delivery of electric current to the at least one electrode modulates afferent neuronal activity.

### Claim 84 (depends on 68)

The method of claim 68, wherein delivery of electric current to the at least one electrode modulates both efferent and afferent neuronal activity.

### Claim 85

A method for renal neuromodulation, said method comprising the steps of:
providing an expandable support member having a cuff-like configuration and comprising a main body portion, the main body portion including a lumen for engaging a wall of a blood vessel comprising a portion of a renal vasculature, at least one electrode connected with the main body portion arranged to selectively deliver electric current to a desired location, and an insulative material attached to at least a portion of the main body portion;
implanting the main body portion extravascularly so that the main body portion is in direct contact with a portion of the renal vasculature and at least one electrode is positioned substantially adjacent a desired location where modulation of the sympathetic nervous system (SNS) is effective to alter renal function; and
delivering electric current to the at least one electrode to effect a change in the SNS.

### Claim 86 (depends on 85)

The method of claim 85, wherein said step of implanting the main body portion extravascularly includes positioning the at least one electrode substantially adjacent a desired location where modulation of the parasympathetic nervous system (PNS) and the SNS is effective to alter renal function.

### Claim 87 (depends on 85)

The method of claim 85, wherein said step of implanting the main body portion extravascularly includes positioning the at least one electrode substantially adjacent a desired location where modulation of the PNS is effective to alter renal function.

### Claim 88 (depends on 85)

The method of claim 85, wherein the change in the SNS includes a change in neurohormonal activation.

### Claim 89 (depends on 85)

The method of claim 85, wherein said step of implanting the main body portion further includes positioning at least a portion of the main body portion substantially adjacent a desired location on an aortic arterial wall.

### Claim 90 (depends on 85)

The method of claim 85, wherein said step of implanting the main body portion further includes positioning at least a portion of the main body portion substantially adjacent a desired location on a vena cava venous wall.

### Claim 91 (depends on 85)

The method of claim 85, wherein the change in the SNS is chemically induced by at least one pharmacological agent associated with the expandable support member.

### Claim 92 (depends on 85)

The method of claim 85, wherein the change in the SNS is biologically induced by at least one biological agent associated with the expandable support member.

### Claim 93 (depends on 85)

The method of claim 85, wherein delivery of electric current to the at least one electrode modulates the level of renin.

### Claim 94 (depends on 85)

The method of claim 85, wherein delivery of electric current to the at least one electrode modulates at least one of urine production and blood pressure.

### Claim 95 (depends on 85)

The method of claim 85, wherein delivery of electric current to the at least one electrode modulates vasoconstriction or blood vessel tone.

### Claim 96 (depends on 85)

The method of claim 85, wherein delivery of electric current to the at least one electrode modulates efferent neuronal activity.

### Claim 97 (depends on 85)

The method of claim 85, wherein delivery of electric current to the at least one electrode modulates afferent neuronal activity.

### Claim 98 (depends on 85)

The method of claim 85, wherein delivery of electric current to the at least one electrode modulates both efferent and afferent neuronal activity.
